EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Plasma versus serum for extracellular vesicle (EV) isolation: A duel for reproducibility and accuracy for CNS‐originating EVs biomarker analysis

Hash Brown Taha

Journal of Neuroscience Research · 2023-11 · 101 (11) · 1677-1686

DOI: 10.1002/jnr.25231 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Neuroscience Research, online erschienen am 27.07.2023. Verfasst von Hash Brown Taha. Beteiligte Einrichtung: Department of Integrative Biology & Physiology, University of California Los Angeles, Los Angeles, California, USA. Hauptthemen laut MEDLINE: Extracellular Vesicles. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Blood‐derived extracellular vesicles (EVs) are a popular source of biomarkers for central nervous system (CNS) diseases, but inconsistencies in isolation and analysis hinder their clinical translation. This review summarizes recent studies that investigate the impact of different anticoagulated plasma and serum on the yield, purity, and molecular content of EVs. Specifically, the studies compare ethylenediaminetetraacetic acid (EDTA), citrate, heparin plasma, and serum and highlight the risk of contamination from platelet‐derived EVs. Here, I offer practical guidelines for standardizing EV isolation and analysis, recommending the use of plasma anticoagulated with acid‐citrate‐dextrose (ACD) or citrate followed by EDTA and heparin, subgroup analyses for samples from different biobank repositories, and avoiding serum and plasma‐to‐serum transformation. Other factors like illness, age, gender, meal timing, exercise, circadian timing, and arm pressure during blood draw can alter EV signatures. Yet, how these variables interact with different anticoagulated plasma or serum samples is unclear, necessitating further research. Furthermore, whether the changes are dependent on the isolation or quantification methodology remains an area of investigation. Importantly, the perspective emphasizes the need for consistency in experimental methodologies to improve the reproducibility and clinical applicability of CNS‐originating EV biomarker studies. The proposed guidelines, along with ongoing efforts to standardize blood sample handling and collection, may facilitate the development of more reliable and informative CNS‐originating EV biomarkers for diagnosis, prognosis, and treatment monitoring of CNS diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracellular VesiclesEdetic AcidReproducibility of ResultsHeparinBiomarkers

Stichwörter der Autor:innen

anticoagulantsbiomarkersbloodextracellular vesicleplasmaserum

Substanzen

Edetic AcidHeparinBiomarkers

Autor:innen und Institutionen

  • Department of Integrative Biology & Physiology, University of California Los Angeles, Los Angeles, California, USA.

Zitieren

APA

Taha, H. B. (2023). Plasma versus serum for extracellular vesicle (EV) isolation: A duel for reproducibility and accuracy for CNS‐originating EVs biomarker analysis. Journal of Neuroscience Research, 101(11), 1677-1686. https://doi.org/10.1002/jnr.25231

Vancouver

Taha HB. Plasma versus serum for extracellular vesicle (EV) isolation: A duel for reproducibility and accuracy for CNS‐originating EVs biomarker analysis. Journal of Neuroscience Research. 2023;101(11):1677-1686. doi:10.1002/jnr.25231

BibTeX
@article{Taha2023,
  author = {Taha, Hash Brown},
  title = {Plasma versus serum for extracellular vesicle (EV) isolation: A duel for reproducibility and accuracy for CNS‐originating EVs biomarker analysis},
  journal = {Journal of Neuroscience Research},
  year = {2023},
  volume = {101},
  number = {11},
  pages = {1677--1686},
  doi = {10.1002/jnr.25231}
}
Kostenlos starten →